Drug Reference
Polyethylene Glycol 3350
OTC
Fact box
- Action class
- Osmotic Laxative
- Mechanism
- Osmotic Activity
- Habit forming
- No
- Availability
- Over-the-counter (OTC)
Brand names
ClearLaxComfortlaxDulcolax OsmoticGaviLyte-CGaviLyte-NGavilaxGavilyte-GGavilyte-HGentleLaxGolytelyHealthyLaxMiralaxMoviPrepPureLaxTriLyte
Available as
210000 MG · Powder100000 MG · Powder7540 MG · Powder900 MG · Powder4700 MG · Powder420000 MG · Powder17000 MG · Powder240000 MG · Powder236000 MG · Powder
FDA label sections are from openFDA and may not reflect the most recent labeling — confirm against the current DailyMed label.
Uses
Use relieves occasional constipation (irregularity) generally produces a bowel movement in 1 to 3 days
How to use / dosing
Directions do not take more than directed unless advised by your doctor this product is supplied with a dosing cup marked to contain 17 grams of powder when filled to the indicated line adults and children 17 years of age and older: use once a day fill to the indicated 17 grams line on cup which is marked to indicate the correct dose 17 grams stir and dissolve in any 4 to 8 ounces of beverage (cold, hot or room temperature) then drink do not combine with starch-based thickeners used for difficulty swallowing ensure that the powder is fully dissolved before drinking do not drink if there are any clumps do not use no more than 7 days children 16 years of age or under: ask a doctor
Safety advice
Conservative summary derived from FDA labeling — defaults to “consult your doctor” unless the label is explicit. Not a substitute for your clinician’s advice.
PregnancyNo information
No specific information in the FDA label.
BreastfeedingNo information
No specific information in the FDA label. Check LactMed →
AlcoholNo information
No specific information in the FDA label.
DrivingNo information
No specific information in the FDA label.
KidneyNo information
No specific information in the FDA label.
LiverNo information
No specific information in the FDA label.
Warnings & precautions
Warnings Allergy alert: Do not use if you are allergic to polyethylene glycol
Current FDA labels (DailyMed)
- DULOXETINE CAPSULE, DELAYED RELEASE [SOLCO HEALTHCARE US, LLC]
- PEG3350 (POLYETHYLENE GLYCOL 3350) POWDER, FOR SOLUTION [MAJOR PHARMACEUTICALS]
- TADALAFIL TABLET [NUCARE PHARMACEUTICALS, INC.]
- MEDROXYPROGESTERONE ACETATE INJECTION, SUSPENSION [PRASCO LABORATORIES]
- SLYND (DROSPIRENONE) KIT [EXELTIS USA, INC.]
Authoritative sources
Reference only — not clinical advice. Verify against current FDA labeling and consult a licensed provider. About half of pediatric drug use is off-label and is not reflected in FDA labels; absence of pediatric information does not mean a medicine is unused or unsafe in children.